Actinium Pharmaceuticals, Inc.
501 Fifth Avenue
New York City
New York
10017
United States
Tel: 646-459-4201
358 articles about Actinium Pharmaceuticals, Inc.
-
Actinium Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock
2/6/2015
-
MD Anderson Cancer Center Department Chair Richard E. Champlin, M.D. Joins Actinium Pharmaceuticals, Inc.’s Iomab™-B Scientific Advisory Board
9/10/2014
-
Actinium Pharmaceuticals, Inc. Files Orphan Drug Application For Use Of Actimab-A In The Treatment Of Newly Diagnosed Acute Myeloid Leukemia In Elderly Patients
9/3/2014
-
Actinium Pharmaceuticals, Inc. To Present At Rodman & Renshaw Annual Global Investment Conference On September 10th
8/28/2014
-
Actinium Pharmaceuticals, Inc. To Present At The Canaccord Genuity 34th Annual Growth Conference On August 13th
8/5/2014
-
Actinium Pharmaceuticals, Inc. Provides Mid-Year Update Directed At Existing And Future Shareholders
8/4/2014
-
Baylor Sammons Cancer Center Joins As Clinical Trial Site For Actinium Pharmaceuticals, Inc.’s Actimab-A Clinical Trial
7/30/2014
-
Actinium Pharmaceuticals, Inc. Announces Launch Of Additional Antibody Actinium-225 Labeling Program
7/16/2014
-
Actinium Pharmaceuticals, Inc. Announces Exercise Of Greenshoe Option
7/11/2014
-
Baylor Oncology Medical Director Joins Actinium Pharmaceuticals, Inc.’s Iomab-B Scientific Advisory Board
7/8/2014
-
Actinium Pharmaceuticals, Inc. Joins Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes
7/1/2014
-
Actinium Pharmaceuticals, Inc. Closes Public Offering Of Common Shares
6/30/2014
-
Actinium Pharmaceuticals, Inc. Prices $12.5 Million Public Offering Of Common Shares
6/25/2014
-
Actinium Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Shares
6/25/2014
-
Actinium Pharmaceuticals, Inc.’s Actimab-A And Alpha-Particle Immunotherapy Platform Further Validated At Society For Nuclear Medicine Annual Meeting
6/24/2014
-
Actinium Pharmaceuticals, Inc. To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention In San Diego On June 26th
6/23/2014
-
Actinium Pharmaceuticals, Inc. Set To Join Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes
6/17/2014
-
Actinium Pharmaceuticals, Inc. Engages A Leading CRO To Support Phase 3 Trial Of Iomab-B
6/16/2014
-
Actinium Pharmaceuticals, Inc. KOL Joseph Jurcic, MD To Discuss The Role Of Actinium’s Alpha-Particle Radiopharmaceuticals In The Treatment Of Leukemia Patients At The 2014 Society of Nuclear Medicine And Molecular Imaging Annual Meeting
6/5/2014
-
Actinium Pharmaceuticals, Inc. Expands Into Additional Offices In Metro Park In Edison, NJ To Support Growing Operations
6/2/2014